Research and Reports in Pulmonology

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +44-1518-081136

Perspective - Research and Reports in Pulmonology (2023) Volume 4, Issue 2

Granulomatous Lung Disease and Its Association with Autoimmune Disorders.

Truman Morrison*

Department of Medicine, Northwestern University Feinberg School of Medicine and Jesse Brown VA Medical Center, United States

Corresponding Author:
Truman Morrison
Department of Medicine
North-western University
Feinberg School of Medicine and Jesse Brown VA Medical Centre, USA
E-mail: morrisont@hyit.edu

Received: 21-Mar-2023, Manuscript No. AARRP-23-91252; Editor assigned: 23-Mar-2023, PreQC No. AARRP-23-91252(PQ); Reviewed: 06-Apr-2023, QC No. AARRP-23-91252; Revised: 11-Apr-2023, Manuscript No. AARRP-23-91252(R); Published: 18-Apr-2023, DOI:10.35841/aarrp-4.2.138

Citation: Morrison T. Granulomatous lung disease and its association with autoimmune disorders. Res Rep Pulmonol. 2023;4(2):138

Visit for more related articles at Research and Reports in Pulmonology

Abstract

Granulomatous Lung Disease (GLD) is a heterogeneous group of disorders characterized by the presence of granulomas in the lung tissue. While the pathogenesis of GLD is not fully understood, recent evidence suggests an association between GLD and autoimmune disorders. Autoimmune disorders are characterized by a deregulated immune response that leads to tissue damage and dysfunction. This perspective discusses the current understanding of the association between GLD and autoimmune disorders, including the potential mechanisms and implications for diagnosis and treatment.

Keywords

Granulomatous lung disease, Autoimmune disorders, Tissue damage.

Introduction

GLD encompasses a range of disorders, including sarcoidosis, hypersensitivity pneumonitis, and Granulomatosis with Polyangiitis (GPA), among others [1]. While the exact cause of GLD remains unknown, recent evidence suggests a potential link between GLD and autoimmune disorders.

Autoimmune disorders are characterized by a deregulated immune response that leads to tissue damage and dysfunction. The presence of autoantibodies and immune complexes in GLD suggests that autoimmunity may play a role in the pathogenesis of these disorders. Several studies have reported an increased prevalence of autoimmune disorders in patients with GLD, particularly sarcoidosis and GPA [2].

Sarcoidosis is a systemic disorder characterized by noncaseating granulomas in various organs, including the lungs. Recent evidence suggests that sarcoidosis may be triggered by an autoimmune response to an unknown antigen. The presence of autoantibodies, including rheumatoid factor and antinuclear antibodies, has been reported in patients with sarcoidosis [3]. Additionally, genetic studies have identified several susceptibility genes associated with sarcoidosis, many of which are also associated with autoimmune disorders.

GPA is a vacuity that affects small to medium-sized blood vessels, including those in the lungs. Recent evidence suggests that GPA may be associated with autoimmunity, although the exact mechanism is not well understood. Studies have identified the presence of autoantibodies, including antineutrophil cytoplasmic antibodies (ANCA), in patients with GPA [4]. Additionally, genetic studies have identified several susceptibility genes associated with GPA, many of which are also associated with autoimmune disorders.

The association between GLD and autoimmune disorders has implications for diagnosis and treatment. Patients with GLD may present with features of an underlying autoimmune disorder, such as arthralgias, skin rash, or renal dysfunction [5]. These features may warrant further investigation for an underlying autoimmune disorder. Additionally, treatment of GLD may involve immunosuppressive therapy, particularly in cases where the disease is associated with an underlying autoimmune disorder [6].

Conclusion

GLD is a heterogeneous group of disorders characterized by the presence of granulomas in the lung tissue. Recent evidence suggests an association between GLD and autoimmune disorders, although the exact mechanism is not well understood. The presence of autoantibodies and immune complexes in GLD suggests that autoimmunity may play a role in the pathogenesis of these disorders. This association has implications for diagnosis and treatment, as patients with GLD may present with features of an underlying autoimmune disorder and may require immunosuppressive therapy. Further research is needed to better understand the association between GLD and autoimmune disorders and to develop more effective therapies for these conditions.

References

  1. Mukhopadhyay S, Gal AA. Granulomatous lung disease: an approach to the differential diagnosis. Arch Pathol Lab Med. 2010;134: 667–90.

    2. Indexed at, Google Scholar, Cross Ref

  2. Woodard BH, Rosenberg SI, Farnham R, et al. Incidence and nature of primary granulomatous inflammation in surgically removed material. Am J Surg Pathol. 1982;6:119–29.

    3. Indexed at, Google Scholar, Cross Ref

  3. Katzenstein ALA. Katzenstein and Askin's surgical pathology of non-neoplastic lung disease. Philadelphia. 2006.

    4. Indexed at, Google Scholar

  4. Kommareddi S, Abramowsky CR, Swinehart GL, et al. Nontuberculous mycobacterial infections: comparison of the fluorescent auramine-O and Ziehl–Neelsen techniques in tissue diagnosis. Hum Pathol.1984;15:1085–9.

    5. Indexed at, Google Scholar, Cross Ref

  5. Eom JS, Mok JH, Lee MK, et al. Efficacy of TB-PCR using EBUS-TBNA samples in patients with intrathoracic granulomatous lymphadenopathy. BMC Pulm Med. 2015;15:1-7.

    6. Indexed at, Google Scholar, Cross Ref

  6. Dhooria S, Agarwal R, Aggarwal AN, et al. Differentiating tuberculosis from sarcoidosis by sonographic characteristics of lymph nodes on endobronchial ultrasonography: a study of 165 patients. J Thorac Cardiovasc Surg. 2014;148:662–7.

    7. Indexed at, Google Scholar, Cross Ref

Get the App